Elicvis (apixaban) coated tablets 2.5 mg. №20


Manufacturer: USA



Prevention of venous thromboembolism in adult patients who have undergone elective knee or hip replacement surgery. Prevention of strokes and systemic embolism in adult patients with non-valvular atrial fibrillation who have one or more risk factors, such as a history of stroke or transient ischemic attack, age 75 or older, hypertension, diabetes mellitus, and symptomatic heart failure (at least class II according to the new York heart Association classification). Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as prevention of relapses of DVT and PE in adults (for information about patients who suffer from PE and have unstable hemodynamics, see the section “application Features”).